Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
321912 | European Neuropsychopharmacology | 2010 | 9 Pages |
Abstract
The antidepressant-like effect of trans-resveratrol, a phenolic compound present in polygonum cuspidatum, was evaluated through behavioral and neurochemical methods. trans-Resveratrol (20, 40 and 80 mg/kg, via gavage) significantly decreased the immobility time in mouse models of despair tests, but did not influence locomotor activity. Two behavioral models and neurochemical assays suggested that trans-resveratrol produced a significant increase in serotonin and noradrenaline levels at 40 or 80 mg/kg in brain regions. In addition, trans-resveratrol dose dependently inhibited MAO-A activity. These findings indicate that the antidepressant-like effect of trans-resveratrol might be related to serotonergic and noradrenergic activation.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Ying Xu, Zhichao Wang, Wenting You, Xiuhua Zhang, Shan Li, Philip A. Barish, Matthew M. Vernon, Xia Du, Gaowen Li, Jianchun Pan, William O. Ogle,